Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Israel Medical Association Journal : IMAJ|October 2, 2014
Omalizumab therapy for chronic spontaneous urticaria: the Israeli experienceMenachem Rottem, Ramit Segal, Shmuel Kivity, et al.Journal of Crohn'S & Colitis|June 21, 2015
Infliximab-Related Infusion Reactions: Systematic ReviewLev Lichtenstein, Yulia Ron, Shmuel Kivity, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema AttacksTimothy Craig, Bruce Zuraw, Hilary Longhurst, et al.The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.The New England Journal of Medicine|September 8, 2010
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaMarco Cicardi, Aleena Banerji, Francisco Bracho, et al.Pageof 4